Search

Author/Creator Jornayvaz, Francois R.

1. Canakinumab in patients with COVID-19 and type 2 diabetes – A multicentre, randomised, double-blind, placebo-controlled trial. (November 2022)

Authors:
Hepprich, Matthias; Mudry, Jonathan M.; Gregoriano, Claudia; Jornayvaz, Francois R.; Carballo, Sebastian; Wojtusciszyn, Anne; Bart, Pierre-Alexandre; Chiche, Jean-Daniel; Fischli, Stefan; Baumgartner, Thomas; Cavelti-Weder, Claudia; Braun, Dominique L.; Günthard, Huldrych F.; Beuschlein, Felix; C...
Journal:
EClinicalMedicine
Issue:
Volume 53(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Second‐generation antisense oligonucleotides against β‐catenin protect mice against diet‐induced hepatic steatosis and hepatic and peripheral insulin resistance. Issue 3 (7th December 2015)

Authors:
Popov, Violeta B.; Jornayvaz, Francois R.; Akgul, Emin O.; Kanda, Shoichi; Jurczak, Michael J.; Zhang, Dongyan; Abudukadier, Abulizi; Majumdar, Sachin K.; Guigni, Blas; Petersen, Kitt Falk; Manchem, Vara Prasad; Bhanot, Sanjay; Shulman, Gerald I.; Samuel, Varman T.
Journal:
FASEB journal
Issue:
Volume 30:Issue 3(2016)
Page Start:
1207
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search